Involved field radiation therapy and donor lymphocyte infusion for relapsed or refractory non-Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation

International Journal of Hematology

Volumn 88, Issue 4, 2008, Pages 463-464

  Behre, G ^a   Christopeit, M ^a   Weber, T ^a  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RELAPSE; CASE REPORT; DONOR LYMPHOCYTE INFUSION; HUMAN; LARGE CELL LYMPHOMA; LETTER; MARGINAL ZONE LYMPHOMA; MULTIMODALITY CANCER THERAPY; NONHODGKIN LYMPHOMA; SAFETY; THERAPY EFFECT; TREATMENT OUTCOME; ALLOTRANSPLANTATION; FEMALE; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LIVING DONOR; LYMPHOCYTE TRANSFUSION; MALE; RADIOGRAPHY; RADIOTHERAPY; RECURRENT DISEASE;

FEMALE; GRAFT VS TUMOR EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMIBODY IRRADIATION; HUMANS; LIVING DONORS; LYMPHOCYTE TRANSFUSION; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; RECURRENCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 64249104607     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0174-4     Document Type: Letter

References (2)

1. C Schmid M Labopin A Nagler M Bornhäuser J Finke A Fassas 2007 EBMT Acute Leukemia Working Party. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party J Clin Oncol 25 4938 45 10.1200/JCO.2007.11.6053
2. AJ Bloor K Thomson N Chowdhry S Verfuerth SJ Ings R Chakraverty 2008 High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma Biol Blood Marrow Transplant 14 50 8 10.1016/j.bbmt.2007.04.013